- Kailera says obesity pill succeeds in late-stage trial in China<figure><div><img src="https://imgproxy.divecdn.com/sHvIDEWnHWODDKUtbWbg7nZxoWKQNqB4C54nc9z4iH4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc4ODI5MzYyLmpwZ…BioPharma Dive · 19d ago↗ source
- STAT+: The crumbling employer-based health insurance systemToday's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance.STAT · 19d ago↗ source
- Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filingCompass Pathways said Tuesday that patients in the second of its two pivotal psilocybin trials maintained their response to treatment for at least six months, keeping the company on track to comple…